2 minute read

MEET THE BOARD

Participants may access the dashboard at AAN.com/Benchmark

The Academy thanks the thousands of members who completed the survey, because without you, we could not maintain the survey’s status as the largest and most robust source of neurology data available. With this essential resource, neurologists, advanced practice providers, and business administrators can find the data needed to make informed decisions, analyze gaps, and identify opportunities. Members who did not participate in the survey may access the data for $500 ($1,500 for nonmembers). A complimentary executive summary is available at AAN.com/Benchmark to obtain a sneak peek at the insightful information. 

Meet Your New Board Member: Nimish A. Mohile, MD, FAAN

Nimish A. Mohile, MD, MS, FAAN, is the Ann Aresty Camhi Professor of Neurology at the University of Rochester, where he serves as the division chief of neuro-oncology and the associate chair for academic affairs. He is a graduate of Duke University, where he first became inspired by neuroscience. As an advocate for advancing equity in the profession of neurology, Mohile aspires to help organizations become fully inclusive and equitable entities. At the AAN, he is currently the chair of the Anti-racism Curriculum Working Group and has taken on the role of chair for the newly created Diversity, Equity, and Inclusion Committee.

How did you initially get involved as a volunteer member for the

AAN?

I first got involved in the AAN by attending Neuro-oncology Section meetings and dinners at the Annual Meeting. They were fantastic opportunities to network, make friends, and find collaborators. A conversation at one of these dinners led me to propose my first (and still favorite) course at the Annual Meeting, “Neuro-oncologic Emergencies.” As an early career member that no one knew, with no prior experience and no connections— the AAN gave me an opportunity based on a good idea and a willingness to do the work. I loved that about the AAN! In the following years, I sought out ways to get engaged in leadership programs and educational courses, doing reviews for Neurology (in italics) He means the journal. , and serving on committees. Today, I have the privilege of chairing the Neuro-oncology Section and in that role, I work intentionally to find ways to help section members identify opportunities in the AAN.

Why did you wish to be on the Board of Directors?

The AAN has committed itself to becoming a diverse and equitable organization and I genuinely believe that over the next decade, the AAN will have a profound impact on diversity, equity, and inclusion for neurologists in all settings. We have an opportunity to create a diverse cadre of future neurologists and provide members with the tools and resources they need to provide equitable access to care and research for their patients. I am excited and feel inspired to work with, contribute to, and help steer an organization with that kind of commitment.

What experiences and viewpoints do you bring to this role?

I bring the experience of an academic neurologist, a neurooncologist, a clinical trialist, and a diversity officer. I have also spent a lot of time developing mentoring programs, strengthening faculty development, and reforming how we think about promotions and tenure. In all these roles, I have really tried to improve, reform, and modernize the processes, structures, and culture of academic neurology to make it more fair, transparent, and equitable. But what I love most about my job is seeing patients and I hope that I can also offer the perspectives of my patients who too often feel like our understanding of neurologic disease is not advanced enough, that accessing research is complicated and cumbersome, and receiving great medical care seems harder every day. 

This article is from: